Bioengineering of vascular macrodevices for transplantation of insulin-producing cells
{{output}}
Type 1 diabetes (T1D) is caused by the autoimmune destruction of insulin-producing cells (IPCs), resulting in disruptions to blood glucose regulation. Cell therapy is an established, FDA-approved treatment for T1D. Incorporating IPCs into vascularized devices ... ...
